Amit Assa - Publications

Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update.

Journal: Journal of Crohn's & colitis

Published: August 20, 2026

Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration.

Journal: Clinical pharmacokinetics

Published: November 28, 2025

Assessment of professional practise on Helicobacter pylori in paediatrics: A pan-European study.

Journal: Journal of pediatric gastroenterology and nutrition

Published: October 14, 2025

Author's Reply: Comment on ``A switch to infliximab may be more effective than ustekinumab following adalimumab pharmacodynamic failure in paediatric patients with Crohn's disease''.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 25, 2025

Multi-omics-based machine learning model predicts response and guides treatment in Crohn disease: a case study in nutritional therapy.

Journal: Inflammatory bowel diseases

Published: August 28, 2025

Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study.

Journal: Inflammatory bowel diseases

Published: June 21, 2025

Drugs in focus: Budesonide and its role in paediatric gastrointestinal disorders.

Journal: Journal of pediatric gastroenterology and nutrition

Published: June 17, 2025

Response to Letter to the Editor on 'Approach to anaemia in gastrointestinal disease: A position paper by the ESPGHAN Gastroenterology Committee'.

Journal: Journal of pediatric gastroenterology and nutrition

Published: June 16, 2025

Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration.

Journal: Clinical pharmacokinetics

Published: May 16, 2025

A switch to infliximab may be more effective than ustekinumab following adalimumab pharmacodynamic failure in paediatric patients with Crohn's disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 21, 2025

The Genetic Architecture of Congenital Diarrhea and Enteropathy.

Journal: The New England journal of medicine

Published: April 02, 2025

Pediatric autoimmune gastritis: An international, multicentric study.

Journal: Journal of pediatric gastroenterology and nutrition

Published: April 02, 2025